Terms ending in 2038
Every in-force patent on Natera, Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,241,117 | Methods for Characterizing Copy Number Variation Using Proximity-Litigation Sequencing In force · High confidence | Natera, Inc. | In force | High confidence | |
| US 10,894,976 | Compositions, Methods, and Kits for Isolating Nucleic Acids In force · High confidence | Natera, Inc. | In force | High confidence | |
| US 12,571,034 | Compositions and Methods for Identifying Nucleic Acid Molecules In force · Medium confidence | Natera, Inc. | In force | Medium confidence | |
| US 11,485,996 | Methods for Characterizing Copy Number Variation Using Proximity-Litigation Sequencing In force · High confidence | Natera, Inc. | In force | High confidence | |
| US 12,260,934 | Systems and Methods for Detection of Aneuploidy In force · High confidence | Natera, Inc. | In force | High confidence | |
| US 12,084,720 | Assessing Graft Suitability for Transplantation In force · High confidence | Natera, Inc. | In force | High confidence | |
| US 11,479,812 | Methods and Compositions for Determining Ploidy In force · High confidence | Natera, Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.